/
TOYO Co., Ltd. is a solar solutions company focused on the research, production, and sale of solar cells, photovoltaic modules, and related products. The company operates across multiple stages of the solar value chain, including wafer and silicon sourcing, solar cell manufacturing, and module assembly, allowing it to serve a broad range of customers in the clean energy industry. Its business is centered on delivering integrated solar products that support utility-scale, commercial, and industrial energy applications. TOYO Co., Ltd. has manufacturing operations and sales activities spanning Asia and the United States, reflecting its role in global solar supply chains. Headquartered in Tokyo, Japan, the company is positioned as a specialist in solar manufacturing and supply, contributing to the availability of renewable energy technologies in international markets.
$5.16
$0.06 (-1.15%)
Live · 07:55 PM
13.81% operating margin is respectable but not wide. ROIC at 26.29%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue up 141.5% YoY with margins expanding 8.8pp.
Even for strong businesses, today's 5x P/E means the stock needs to keep delivering. There's no margin of safety if growth disappoints.
5.3x earnings, 4.7x FCF. The multiple is below average. Either the market is pricing in deterioration you should investigate, or there's genuine value here.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (FY)
$427M
▲ +141.5% YoY
Net Income (FY)
$37M
▼ -8.3% YoY
Op. Margin
13.81%
▲ +8.8pp YoY
ROIC
26.29%
▲ +17.7pp YoY
Cash Flow & Balance Sheet
FCF (FY)
$41M
▲ +1574.5% YoY
Op. Cash Flow (FY)
$127M
▲ +427.0% YoY
Net Debt
$22M
Cash & Equiv.
$52M
Continue Research
At a P/E of 5.3 and a price-to-free-cash-flow of 4.7, TOYO Co. (TOYO) trades below a two-stage DCF intrinsic value of about $54.64 per share, so at $5.16 the stock looks undervalued (959.0% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, TOYO Co. scores 66/100 on Intrinsiqq's quality scorecard (a solid business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about $54.64 per share for TOYO, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $40.98. At today's $5.16, that puts the stock about 959.0% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
TOYO Co. scores 66 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a solid business on these measures. Recent fundamentals include a 13.8% operating margin and a 26.3% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. TOYO currently trades below its estimated intrinsic value and scores 66/100 on quality (solid). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.